About the Authors
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia
RHB has a patent relating to ex vivo ELISPOT licensed through Oxford University.
PCH, RHB, AF, and KPM designed the study. PCH, DJS, IMA, and AMA were responsible for field and clinical aspects. RHB, AF, MDL, BCdJ, and RAA performed laboratory procedures and interpretation. PCH, DJJ, and SAD performed statistical data analysis. All authors contributed to writing the paper.